⌘K

Login Start Free

Home/Filings/4/0001209191-22-007046

4//SEC Filing

Burak Eric 4

Accession 0001209191-22-007046

CIK 0001805890other

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 7:36 PM ET

Size

5.3 KB

Accession

0001209191-22-007046

Insider Transaction Report

Form 4

Period: 2022-02-01

Fusion Pharmaceuticals Inc.FUSN

Chief Scientific Officer

Transactions

Award
Stock Option (Right to Buy)
2022-02-01+168,200→ 168,200 total
Exercise: $7.70Exp: 2032-02-01→ Common Stock (168,200 underlying)

Footnotes (1)

[F1]This option vests in 48 equal monthly installments beginning on March 1, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Fusion Pharmaceuticals Inc.

CIK 0001805890

Entity typeother

Related Parties

1

filerCIK 0001813701

Filing Metadata

Form type: 4
Filed: Feb 2, 7:00 PM ET
Accepted: Feb 3, 7:36 PM ET
Size: 5.3 KB

View on SEC.gov